Prognosis for Patients after Pulmonary Embolism and its Determining Factors (Results of 12-Month Follow-Up)
- Authors: Terekhovskaya Y.V.1, Akhmedova N.E.2, Leonenko D.I.2, Nikulina N.N.2
-
Affiliations:
- Ryazan Regional Clinical Cardiology Dispensary
- Ryazan State Medical University
- Issue: Vol 31, No 1 (2023)
- Pages: 49-58
- Section: Original study
- URL: https://journals.rcsi.science/pavlovj/article/view/252522
- DOI: https://doi.org/10.17816/PAVLOVJ165196
- ID: 252522
Cite item
Abstract
INTRODUCTION: Pulmonary embolism (PE) is a cardiovascular disease with high mortality: according to autopsy data, PE is the cause of death in every tenth deceased person. Despite a relatively long history of studying PE, the literature data on this problem are scattered, incomplete and often do not represent the Russian population.
AIM: To evaluate 12-month survival rate of patients after a past episode of PE and to establish predictors of fatal outcome.
MATERIALS AND METHODS: The work was carried out within the Russian SIRENA register. The study included 107 patients (age median and interquartile range 63 (52–74) years), who underwent inpatient treatment in Regional Clinical Cardiologic Dispensary of Ryazan (hospitalization from 01.05.2018 to 31.05.2019; inclusion period 13 months). In the period of hospitalization, the information was taken from the data of medical records and objective examinations, and after the discharge — through telephone control. Follow-up period from the moment of hospitalization was 12 months; response — 84.5%.
RESULTS: The 12-month survival rate of patients with PE was 77.1%; recurrence of venous thromboembolism developed in 6.5% of patients, bleeding — in 22.4% of patients. The only statistically significant predictor of the development of a fatal outcome after discharge from hospital was the presence of cancer, including that in history (relative risk (RR) 4.4; 95% confidence interval (CI) 1.4–14.5; p = 0.014). The leading predictors of death from the moment of hospitalization within 12 months were high risk based on the integral assessment of severity and of early death risk (RR 9.9; 95% CI 1.2–79.5; p = 0.031), age ≥ 65 years (RR 5.1; 95% CI 1.7–15.2; p = 0.003), hospitalization with other than PE primary diagnosis (RR 4.5; 95% CI 1.9–10.8; p = 0.001), impaired filtration function of kidneys (RR 4.3; 95% CI 1.7–11.1; p = 0.003). Besides, a statistically significant increase in the risk of death during this period was associated with history of atherosclerotic diseases, stroke, heart failure, oncology, hemodynamic instability in the acute period, the need for loop diuretics during hospitalization and the presence of S1Q3 syndrome.
CONCLUSION: The mortality rate of patients with PE in one of the regional vascular centers of Ryazan in 2018–2019 generally agrees with the data of the previous international studies. The leading predictors of fatal outcome within 12 months from the moment of hospitalization include a severe condition of a patient at the time of hospitalization, age ≥ 65 years, untimely diagnosis of PE and reduction of filtration function of kidneys.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Yuliya V. Terekhovskaya
Ryazan Regional Clinical Cardiology Dispensary
Author for correspondence.
Email: Shera_11.11@mail.ru
ORCID iD: 0000-0002-9537-1618
SPIN-code: 4980-9875
Russian Federation, Ryazan
Nazly E. kyzy Akhmedova
Ryazan State Medical University
Email: ahmedova_an@mail.ru
ORCID iD: 0000-0002-4050-7389
Russian Federation, Ryazan
Dar'ya I. Leonenko
Ryazan State Medical University
Email: ossslacrimale@mail.ru
ORCID iD: 0000-0002-3068-3127
Russian Federation, Ryazan
Natal’ya N. Nikulina
Ryazan State Medical University
Email: Natalia.Nikulina@mail.ru
ORCID iD: 0000-0001-8593-3173
SPIN-code: 9486-1801
MD, Dr. Sci. (Med.), Associate Professor
Russian Federation, RyazanReferences
- Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). European Heart Journal. 2020; 41:543–603. doi: 10.1093/eurheartj/ehz405
- Barco S, Mahmoudpour SH, Valerio L, et al. Trends in mortality related to pulmonary embolism in the European Region, 2000-15: analysis of vital registration data from the WHO Mortality Database. The Lancet. Respiratory Medicine. 2020;8(3):277–87. doi: 10.1016/S2213-2600(19)30354-6
- Nikulina NN, Terekhovskaya YuV. Epidemiology of pulmonary embolism in today’s context: analysis of incidence, mortality and problems of their study. Russian Journal of Cardiology. 2019;24(6):103–08. (In Russ). doi: 10.15829/1560-4071-2019-6-103-108
- Puurunen MK, Gona PN, Larson MG, et al. Epidemiology of venous thromboembolism in the Framingham Heart Study. Thrombosis Research. 2016;145:27–33. doi: 10.1016/j.thromres.2016.06.033
- Zatevakhin II, Tsitsiashvili MSh, Mishnev AD, et al. Posleoperatsionnyye venoznyye tromboembolicheskiye oslozhneniya, naskol’ko real’na ugroza? Angiology and Vascular Surgery. 2002;8(1):17–21. (In Russ).
- Fedorov SA, Medvedev AP, Tselousova LM, et al. Differential Approach to Surgical and Endovascular Treatments of Pulmonary Thromboembolism in Patients with Neurological and Neurosurgical Problems. I. P. Pavlov Russian Medical Biological Herald. 2022;30(2):223–32. (In Russ). doi: 10.17816/PAVLOVJ886716
- Erlikh AD, Atakanova AN, Neeshpapa AG, et al. Russian register of acute pulmonary embolism SIRENA: characteristics of patients and in-hospital treatment. Russian Journal of Cardiology. 2020;25(10):3849. (In Russ). doi: 10.15829/1560-4071-2020-3849
- Yakushin SS, Nikulina NN, Terekhovskaya YuV. Clinical Manifestations and Diagnosis of Pulmonary Embolism in Routine Clinical Practice: Data from the Ryazan Regional Vascular Center. I. P. Pavlov Russian Medical Biological Herald. 2021;30(1):51–62. (In Russ). doi: 10.17816/PAVLOVJ85405
- Nikulina NN, Terekhovskaya YuV, Yakushin SS. Antithrombotic Therapy and the Nearest Forecast of Pulmonary Embolism in Rutine Clinical Practice (Data of the Regional Vascular Center of the Ryazan Region). Rational Pharmacotherapy in Cardiology. 2022;18(2):135–42. (In Russ). doi: 10.20996/1819-6446-2022-04-13
- Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. Archives of Internal Medicine. 1991;151(5):933–8. doi: 10.1001/archinte.1991.00400050081016
- Laporte S, Mismetti P, Décousus H, et al. Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad Trombo Embolica venosa (RIETE) Registry. Circulation. 2008;117(13):1711–6. doi: 10.1161/CIRCULATIONAHA.107.726232
- Pollack CV, Schreiber D, Goldhaber SZ, et al. Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry). Journal of the American College of Cardiology. 2011;57(6):700–6. doi: 10.1016/j.jacc.2010.05.071
- Menzorov MV, Filimonova VV, Erlikh AD, et al. Renal dysfunction in patients with pulmonary embolism: data from the SIRENA register. Russian Journal of Cardiology. 2021;26(2S):4422. (In Russ). doi: 10.15829/1560-4071-2021-4422
- Valerio L, Mavromanoli AC, Barco S, et al. Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study. European Heart Journal. 2022;43(36):3387–98. doi: 10.1093/eurheartj/ehac206
- Van Maanen R, Trinks–Roerdink EM, Rutten FH, et al. A systematic review and meta-analysis of diagnostic delay in pulmonary embolism. European Journal of General Practice. 2020;28(1):165–72. doi: 10.1080/13814788.2022.2086232
- Aujesky D, Obrosky DS, Stone RA, et al. Derivation and validation of a prognostic model for pulmonary embolism. American Journal of Respiratory and Critical Care Medicine. 2005;172(8): 1041–6. doi: 10.1164/rccm.200506-862OC
- Naberezhnaya IB. Provision of People of Retirement Age with High-Tech Medical Care is One of the Most Important Trends of Healthcare Development. Nauka Molodykh (Eruditio Juvenium). 2022;10(2):137–46. (In Russ). doi: 10.23888/HMJ2022102137-146
- Spirk D, Husmann M, Hayoz D, et al. Predictors of in-hospital mortality in elderly patients with acute venous thrombo-embolism: the SWIss Venous ThromboEmbolism Registry (SWIVTER). European Heart Journal. 2012;33(7):921–6. doi: 10.1093/eurheartj/ehr392
- Friz HP, Orenti A, Gelfi E, et al. Predictors of medium- and long-term mortality in elderly patients with acute pulmonary embolism. Heliyon. 2020;6(9):e04857. doi: 10.1016/j.heliyon.2020.e04857